Nanobody-based retargeting of an oncolytic herpesvirus for eliminating CXCR4+ GBM cells: A proof of principle-Reference-Cited by-同舟云学术

Nanobody-based retargeting of an oncolytic herpesvirus for eliminating CXCR4+ GBM cells: A proof of principle

Published:2022-09 Issue: Volume:26 Page:35-48
ISSN:2372-7705
Container-title:Molecular Therapy - Oncolytics
language:en
Short-container-title:Molecular Therapy - Oncolytics

Author:

Sanchez Gil Judit,Dubois Maxime,Neirinckx Virginie,Lombard Arnaud,Coppieters Natacha,D’Arrigo Paolo,Isci Damla,Aldenhoff Therese,Brouwers Benoit,Lassence Cédric,Rogister Bernard,Lebrun Marielle,Sadzot-Delvaux Catherine^ORCID

Publisher

Elsevier BV

Subject

Pharmacology (medical),Cancer Research,Oncology,Molecular Medicine

Reference60 articles.

1. HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor;Feng;Science,1996

2. Overexpression of chemokine receptor CXCR4 predicts lymph node metastatic risk in patients with melanoma: a systematic review and meta-analysis;Alimohammadi;Cytokine,2021

3. CXCL12 expression is predictive of a shorter time to tumor progression in low-grade glioma: a single-institution study in 50 patients;Salmaggi;J. Neurooncol.,2005

4. The role of CXCL12-CXCR4 signaling pathway in pancreatic development;Katsumoto;Theranostics,2013

5. The role of CXCR4 in highly malignant human gliomas biology: current knowledge and future directions;Gagliardi;Glia,2014

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oncolytic virotherapy improves immunotherapies targeting cancer stemness in glioblastoma;Biochimica et Biophysica Acta (BBA) - General Subjects;2024-09

2. Preclinical evaluation of CXCR4 peptides for targeted radionuclide therapy in glioblastoma;EJNMMI Radiopharmacy and Chemistry;2024-07-15

3. Improvement of current immunotherapies with engineered oncolytic viruses that target cancer stem cells;Cell Biochemistry and Function;2024-06

4. Oncolytic herpes simplex viruses designed for targeted treatment of EGFR-bearing tumors;Molecular Therapy: Oncology;2024-03

5. Oncolytic herpes simplex viruses for the treatment of glioma and targeting glioblastoma stem-like cells;Frontiers in Cellular and Infection Microbiology;2023-05-31